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Visual abstract: 1 
Key question: Is trans-thoracic clamping safer than endo-aortic balloon occlusion in minimally 2 
invasive mitral valve surgery? 3 
Key findings: We found similar rates of cerebrovascular accident and survival between the two 4 
approaches. 5 
Take home messages: At present there is little evidence to support one technique over another. A 6 


















Abstract   1 
This systematic review and meta-analysis aims to determine outcomes following aortic occlusion 2 
with the transthoracic clamp (TTC) versus endoaortic balloon occlusion (EABO) in patients 3 
undergoing minimally invasive mitral valve surgery (MIMVS). A subgroup analysis compares TTC to 4 
EABO with femoral cannulation separately from EABO with aortic cannulation. We searched Medline 5 
and Embase up to December 2018. Two people independently and in duplicate screened title and 6 
abstracts, full-text reports, extracted data and assessed risk-of-bias (ROB) using the Cochrane ROB 7 
tool for non-randomised studies. We identified 1564 reports from which 11 observational studies 8 
with 4181 participants met the inclusion criteria. We found no evidence of difference in the risk of 9 
post-operative death or cerebrovascular accident (CVA) between the two techniques. Evidence for a 10 
reduction in aortic dissection with TTC was found: 4/1590 for the TTC group versus 19/2492 for the 11 
EABO group (RR, 0.33, 95% CI, [0.12] to [0.93], p=0.04). There was no difference in aortic cross-12 
clamp (AoX) time between TTC and EABO (mean difference [-5.17] minutes, 95% CI, [-12.40] to 13 
[2.06], p=0.16). TTC was associated with a shorter AoX time compared to EABO with femoral 14 
cannulation (mean difference [-9.26] minutes, 95% CI, [-17.00] to [-1.52], p=0.02). EABO with aortic 15 
cannulation was associated with a shorter AoX time compared to TTC (mean difference [7.77] 16 
minutes, 95% CI, [3.29] to 12.26], p<0.001). There was no difference in cardio-pulmonary bypass 17 
(CPB) time between TTC and EABO with aortic cannulation (mean difference [-4.98] minutes, 95% CI, 18 
[-14.41] to [4.45], p=0.3). TTC was associated with a shorter CPB time compared to EABO with 19 
femoral cannulation (mean difference [-10.08] minutes, 95% CI, [-19.93] to [-0.22], p=0.05). Despite 20 
a higher risk of aortic dissection with EABO, the rates of survival and CVA across the two techniques 21 






Background   1 
Minimally invasive mitral valve surgery (MIMVS) is recognised as a safe surgical approach with 2 
patients reporting less pain, shorter hospital stay and better cosmetic results compared to other 3 
more invasive approaches.1 To perform this, cardiopulmonary bypass (CPB) is needed and aortic 4 
occlusion is a critical step in its setup. This is achieved currently by two techniques available to 5 
surgeons: Transthoracic Clamp (TTC) and Endoaortic Balloon Occlusion (EABO). The TTC technique is 6 
simpler and involves inserting a clamp through the intercostal spaces to clamp the ascending aorta.2 7 
The EABO technique is associated with a longer learning curve as the procedure requires more 8 
monitoring and experience.3 It involves accessing the aorta through a catheter inserted either in the 9 
femoral artery or directly through the ascending aorta with an inflatable balloon at its tip. This is 10 
guided by trans-oesophageal echocardiography (TOE), the balloon is inflated and the aorta occluded. 11 
 12 
A previous meta-analysis of observational studies and abstracts reports that there was no significant 13 
difference in the occurrence of cerebrovascular accidents (CVA) and mortality when comparing TTC 14 
and EABO.4 It however found that EABO was associated with significantly higher risk of iatrogenic 15 
aortic dissection as well as a trend towards increased CPB and aortic cross-clamp (AoX) times. In this 16 
review, we perform a subgroup analysis separating EABO with femoral cannulation to EABO with 17 
aortic cannulation to see if the cannulation approach in EABO has an impact on these clinical 18 
outcomes. In addition, we only include research published in full-text reports aiming to deliver a 19 
more comprehensive assessment of risk of bias. 20 
 21 
Methods   22 
To perform this research, we followed the review process as outlined by the Cochrane Handbook for 23 




Criteria for considering studies for this review 1 
Types of studies 2 
We searched for both observational and randomised studies that compared TTC and EABO in 3 
patients undergoing MIMVS. Studies included reported as full text and excluded those published as 4 
abstract only. No unpublished data was examined. 5 
Types of participants 6 
We included patients of any age, sex or ethnicity with mitral valve (MV) pathology and required 7 
MIMVS. Patients undergoing concomitant surgery alongside MV surgery were not excluded.  8 
Types of interventions 9 
We included studies comparing TTC (also called External Aortic Clamp or External Transthoracic 10 
Aortic Clamp) with EABO (also called Endoaortic Clamp Occlusion [EACO]) in MIMVS.  11 
Types of outcome measures 12 
- Primary outcomes 13 
1. All-cause mortality, within 3 months of MIMVS. 14 
2. CVA <30 days following MIMVS. 15 
3. Aortic dissection. 16 
- Secondary outcomes 17 
1. AoX time (minutes). 18 
2. CPB time (minutes). 19 
Search methods for identification of studies 20 
Electronic search 21 
We searched Medline and Embase on Ovid for published observational and randomised studies 22 
comparing TTC to EABO in MIMVS between January 2000 and December 2018. We decided to use 23 
the year 2000 as a cut off to target the latest reports only.  The following keywords were used:  24 
Minimally Invasive Surgical Procedures, Mitral Valve, mini-MVS, mini-thoracotomy, ministernotomy, 25 
 
 6 
hemisternotomy, endoclamp, endo-aortic, endoluminal, endo-balloon, Chitwood clamp, Intraclude 1 
clamp, Heartport clamp, ESTECH and flex clamp (Appendix 1). 2 
 3 
Data collection and analysis 4 
Statistical and data reporting guidelines for the European Journal of Cardiothoracic Surgery and the 5 
Interactive Cardiovascular and Thoracic Surgery6 were consulted. 6 
Selection of studies 7 
Two reviewers (PR, ZDT) independently screened titles and abstracts for relevance. Any 8 
disagreements were resolved by conversation and consensus was reached with supervision of a 9 
third reviewer (HH). We retrieved the full-text reports and one reviewer (PR) screened these for 10 
inclusion or exclusion. We recorded the selection process and completed a PRISMA7 flow diagram 11 
(Figure 1) and a “Characteristics of excluded studies table” (Appendix 2). 12 
Data extraction and management 13 
Three independent reviewers (PR, TM, AM) performed data collection, including assessment of bias, 14 
for each study and extracted information on the following: 15 
1. Methods: date of study, country of origin, study design. 16 
2. Patient characteristics: total number of patients; and number of patients, mean age, 17 
percentage of female patients and reported previous CVAs in each group. 18 
3. Interventions: type of clamp used in the TTC technique, type of endoballoon used in the 19 
EABO technique, if the EABO approach was with femoral or aortic cannulation. 20 
4. Outcomes: primary and secondary outcomes as reported in the earlier section. 21 
The data was then transferred to Review Manager (Version 5.3. Copenhagen: The Nordic Cochrane 22 
Centre).8 23 
Assessment of risk of bias in included studies 24 
Three independent reviewers (PR, TM, AM) used the Risk Of Bias In Non-randomized Studies of 25 
Interventions (ROBINS-I) tool to assess risk of bias in the included studies.9 This tool assesses risk of 26 
 
 7 
bias by comparing each observational study with a hypothetical target randomized control trial (RCT) 1 
that addresses the same question as the observational study (Appendix 3).  ROBINS-I assesses risk of 2 
bias in seven domains: 3 
1. Bias due to confounding 4 
2. Bias in selection of participants 5 
3. Bias in classification of interventions 6 
4. Bias due to departures from intended intervention 7 
5. Bias due to missing data 8 
6. Bias in measurement outcomes 9 
7. Bias in selection of the reported results 10 
Each domain was marked as having either a low; moderate; high; serious or critical risk of bias. 11 
ROBINS-I requires the pre-specification of confounders. Numerous confounding factors were 12 
identified and could be divided into the two following categories:  13 
- Patient-based confounders: sex, diameter of femoral artery, age, NYHA class, history of 14 
previous CVA, history of previous vascular disease (HTN, diabetes), history of previous 15 
rheumatic heart disease, history of previous cardiac surgery. 16 
- Technical confounders: type of surgery, complexity of the surgery, additional interventions 17 
during the surgery such as maze procedure or tricuspid surgery, use of robotics and surgeon 18 
experience or learning curve. 19 
Surgeon learning curve was accounted for within the domain of “Bias due to confounding”. Studies 20 
which both accounted for this confounding factor and looked balanced for the main baseline 21 
confounders were judged to be at moderate risk of bias for this domain. Finally, in an attempt to 22 
investigate publication bias, we produced a funnel plot looking at the outcome of all cause mortality 23 





Measures of treatment effect 1 
Continuous data was analysed as mean difference (MD) with 95% confidence intervals (CIs). We 2 
analysed dichotomous data as risk ratios (RRs) with 95% confidence intervals (CIs). We chose RRs 3 
over odds ratios because they are considered easier to interpret.5 Events are reported as a number 4 
per cohort and weighted using a random-effects model. 5 
Unit of analysis issues 6 
When collecting data for the CPB and AoX times, we converted any reports that were in “hours” to 7 
“minutes”. In addition, for other outcomes, we converted any reports of “percentage of incidence” 8 
to a “number of events per group” by using the total number of patients in that group.  9 
Assessment of heterogeneity 10 
Chi2 and I2 statistics were used to measure the presence and extent of heterogeneity between the 11 
groups in each analysis. p values were considered statistically significant when ≤0.05.  12 
Data analysis 13 
We used the Mantel-Haenszel method for all meta-analyses with dichotomous outcomes and the 14 
Inverse Variance (IV) random effects model for continuous outcomes according to the guidance in 15 
the Cochrane Handbook for Systematic Reviews of Interventions.5 Due to the heterogeneity of the 16 
interventions and comparators, we used a random-effects model in all instances. We performed all 17 
analyses using Review Manager 5 (RevMan 5) software,8 following an intention-to-treat principle. 18 
 19 
Subgroup analysis 20 
Where there were sufficient numbers of events for a specific outcome we performed subgroup 21 






Summary of findings' tables 1 
We created 'Summary of findings' tables for each intervention type for primary and secondary 2 
outcomes. We used the five GRADE considerations to assess the quality of body of evidence as 3 
described in Section 8.5 and Chapter 12 of the Cochrane Handbook for Systematic Reviews of 4 
Interventions,5 employing GRADEpro GDT software.10  5 
 6 
Results   7 
Results of the search 8 
We identified 11 papers with 4181 participants for inclusion in our review. We retrieved 1564 9 
references from the electronic search of the literature. After removing studies that were clearly not 10 
eligible for inclusion we assessed 24 full-text articles. Of these we excluded 13 studies and recorded 11 
reasons for exclusion (Appendix 2).  12 
Included studies with patient characteristics (Table 1) 13 
Included studies were performed in Germany11,12, Italy14,15,16,17, Canada18, the USA19,20,21 and the 14 
Netherlands.13 All studies were observational with 3 being prospective and 8 being retrospective in 15 
design (Table 1). These represented a total of 4181 patients undergoing MIMVS with cohort sizes 16 
ranging from 36 to 1064 patients. The total number of patients undergoing MIMVS with the TTC 17 
technique was 1606 (38%) as opposed to 2575 (62%) with the EABO technique. Of those, 2056 (80%) 18 
had EABO with femoral cannulation and 519 (20%) had EABO with direct aortic cannulation. Eight 19 
studies used the femoral cannulation technique for EABO.11,12,13,16,17,18,19,20 Two studies used the 20 
direct aortic cannulation technique for EABO.15,21 One study, Barbero et al. (2016),14 offered 2 21 






Risk of bias 1 
Risk of bias is summarised in Table 2. Out of the eleven included studies, nine studies were deemed 2 
to be at an overall ‘serious’ risk of bias while the remaining two were deemed to be at an overall 3 
‘moderate’ risk. The main source of bias was bias due to confounding. 4 
1) Bias due to confounding: 5 
Nine included studies11,12,14,16,17,18,19,20,21 were rated as being at a ‘serious’ risk of bias due to 6 
confounding and two13,15 were rated at a ‘moderate’ risk. Nine studies provided pre-operative 7 
patient characteristics tables. Of these, most reported unbalanced patient characteristics between 8 
TTC and EABO cohorts. All included studies were non-randomised and patient allocation to either 9 
TTC or EABO intervention groups was based on policy of surgical centre at the time of operation, 10 
patient characteristics and surgeon preference. Many studies compared two time periods, one when 11 
EABO was the technique of choice and one when TTC was the preferred technique. This introduces 12 
the possibility of differences in outcome due to differences in surgeon experience in MIMVS and due 13 
to changes in procedures over time which were not controlled for.  14 
2) Bias in selection of participants: 15 
All eleven included studies were at a ‘low’ risk of bias due to selection of participants because 16 
patient selection was not related to the intervention (or the effect of the intervention) and the 17 
outcome. Patients who underwent elective ventricular fibrillation were, for most outcomes, 18 
removed as part of the study designs. 19 
3) Bias in classification of interventions: 20 
All eleven studies were at a ‘low’ risk of bias due to classification of interventions, with both TTC and 21 
EABO interventions groups clearly defined before the start of the operation. 22 
4) Bias due to departures from intended intervention: 23 
All eleven studies were at a ‘low’ risk of bias due to departures from intended intervention.  24 
5) Bias due to missing data: 25 
 
 11 
Eight studies were at a ‘low’ risk of bias due to missing data. Three studies14,16,21 were at a 1 
‘moderate’ risk due to a very small number of patients having been allocated a group and then 2 
dropping out or being excluded from the intervention group due to conversion to full sternotomy or 3 
inadequate data reporting. 4 
6) Bias in measurement of outcomes; 5 
All eleven studies were at a ‘low’ risk of bias in measurement of outcomes as all outcomes were 6 
objective in nature. 7 
7) Bias in selection of the reported results: 8 
All eleven studies were at a ‘moderate’ risk of bias in selection of reported results because there was 9 
no protocol or pre-specified analysis plan. 10 
8) Bias in publication: 11 
A funnel plot was produced to investigate publication bias which showed that studies comparing TTC 12 
to EABO with aortic cannulation could be missing from the literature if they reported a higher risk of 13 
mortality than TTC. Overall however, there did not appear to be a publication bias when comparing 14 
TTC to EABO (Figure 2). 15 
 16 
Summary of bias: 17 
Overall, allocation bias seemed to favour TTC over EABO. Four studies14,18,19,20 favoured TTC over 18 
EABO by having more patients with previous cardiac surgery allocated to their EABO cohorts 19 
compared to their TTC ones. With only two studies13,20 specifically controlling for surgeon experience 20 
by stating that their surgeons had completed the learning curve for MIMVS, we can confidently say 21 
they were competent in both TTC and EABO techniques. All other studies are at risk of having 22 





Primary outcomes 1 
Summary of findings table:  2 
All-cause mortality (Figure 3) 3 
All studies reported all-cause mortality as post-operative mortality within 3 months following the 4 
surgery. In a random effects model, there was no difference in the risk of death between the two 5 
techniques or within any of the subgroups (overall RR, 1.52, 95% CI [0.86] to [2.66], p=0.15, I2=0%).  6 
Cerebrovascular accident (Figure 3) 7 
Ten studies reported CVA either as stroke or transient ischaemic attack (TIA) within 30 days after 8 
surgery. Maselli et al. (2006)15 did not report this outcome and therefore was not included in the 9 
analysis. There was no difference in the risk of CVA between the two techniques in a random effects 10 
model (RR, 0.83, 95% CI [0.48] to [1.44], p=0.5, I2=6%).  11 
Aortic dissection (Figure 3) 12 
For studies comparing TTC to EABO with femoral cannulation there was a significantly lower risk of 13 
aortic dissection with TTC as opposed to the EABO with femoral cannulation (RR, 0.33, 95% CI, [0.12] 14 
to [0.93], p=0.04, I2=0%). None of the studies that compared TTC to EABO with aortic cannulation 15 
found any events of aortic dissection in either group and therefore we did not include them in this 16 
analysis. 17 
 18 
Secondary outcomes 19 
Summary of findings table:  20 
Aortic cross-clamp time (Aox-clamp time) (Figure 4) 21 
Evidence for AoX time in MIMVS was very low (Table 4). The summary estimates for subgroups were 22 
significantly different (test for heterogeneity p<0.001, I2=92%) therefore we focus on the subgroup 23 
summary estimates. AoX time for MIMVS using TTC was on average 9 minutes shorter than EABO 24 
 
 13 
with femoral cannulation (mean difference -9.26 minutes, 95% CI, -17.00 to -1.52 minutes, p=0.02, 1 
I2=84%). In contrast, AoX time for TTC was over 7 minutes longer than EABO with aortic cannulation 2 
(mean difference [7.77] minutes, 95% CI, 3.29 to 12.26 minutes, p<0.001, I2=0%).  3 
 4 
Cardiopulmonary Bypass time (CPB time) (Figure 4) 5 
Evidence for CPB time was very low (see Table 4). The summary estimates for the subgroups were 6 
significantly different (test for heterogeneity p=0.02, I2=82%) therefore we focus on the subgroup 7 
summary estimates. CPB time for MIMVS using TTC was on average 10 minutes faster than CPB 8 
using EABO with femoral cannulation (mean difference -10.08 minutes, 95% CI, -19.93 to -0.22 9 
minutes, p=0.05, I2=87%). The data were heterogeneous (Chi2 test for heterogeneity <0.001; I2 10 
=87%). CPB time for MIMVS using EABO with aortic cannulation was ten minutes faster (mean 11 
difference 10.89 minutes, 95% CI, -3.37 to 25.15 minutes, p=0.13, I2=79%) The data were 12 
heterogeneous (Chi2 test for heterogeneity p<0.001; I2 =79%) and the lower 95% CI indicates CPB 13 
could be 3 minutes longer than when using TTC.  14 
 15 
Discussion   16 
• General summary of results 17 
All studies reported post-operative survival rates. Meta-analysis showed overall good survival rates 18 
with no difference between TTC and the two EABO techniques. However, there was weak evidence 19 
of no difference suggesting that both EABO techniques were associated with fewer post-operative 20 
deaths compared to TTC. The reasons for this were undetermined and most probably secondary to 21 
confounding. Several studies performed multivariable analyses to determine if there were any 22 
predictors of mortality14,19. They found that aortic clamping technique was not a predictor of 23 
mortality but patient pre-operative risk factors such as a NYHA class of III/IV, diabetes, renal failure, 24 
atrial fibrillation, age>70 years as well as prolonged CPB time were. These findings suggest that 25 
patient co-morbidities are more influential on survival rates than aortic occlusion technique. 26 
 
 14 
Ten studies reported post-operative CVA. Meta-analysis showed no difference in risk of CVA with 1 
both techniques overall, and no difference when subgroup analyses were used to explore 2 
differences between TTC and EABO (femoral) and TTC and EABO (aortic). The mean summary 3 
estimates from the subgroup analysis indicate higher risk in the subgroup analysis of CVA with EABO 4 
(femoral) when compared to TTC but an opposite effect of a lower risk of EABO (aortic) when 5 
compared with TTC. However, the 95% CI for both these means cross the null. More evidence from 6 
additional studies would be helpful in determining if these trends persist and inform a hypothesis 7 
that EABO (aortic) is the occlusion approach with the least CVA risk. A previous meta-analysis4 8 
comparing TTC and EABO suggested several reasons for higher incidences of CVA with EABO 9 
(femoral): introduction of a guidewire along the aortic arch/ascending aorta, the balloon catheter 10 
being prone to migration during atrial wall retraction especially in patients with wide aortas and 11 
atheromatous disease and, finally, having to re-position the balloon intra-operatively with deflation 12 
and re-inflation of the balloon which can increase risk of embolization from the aorta. These reasons 13 
can explain why we found EABO (femoral) was associated with higher risk of CVA compared to TTC. 14 
On the other hand, the question still remains regarding how EABO (aortic) has the lowest risk of 15 
CVA. Two papers (Glower et al. (2010)21 and Schmitz et al. (2002)22) have investigated this question 16 
and state that the advantages of the aortic cannulation approach over the femoral approach are a 17 
more direct and controlled placement of the balloon as well as the elimination of balloon migration 18 
because the balloon is pulled snuggly against the fixed aortic cannula and cannot move. In addition, 19 
we found EABO (aortic) was associated with the shortest AoX time and CPB times which suggests 20 
shorter extra-corporeal support times may be another reason for a low risk of CVA. Overall, both TTC 21 
and EABO are associated with similarly low risks of CVA; however EABO (aortic) seems the least risk 22 
prone for this outcome. 23 
 24 
Ten studies reported AoX-clamp and CPB times. Meta-analysis showed no difference in length of 25 
AoX times and CPB times between TTC and the pooled EABO techniques. Overall, it showed weak 26 
 
 15 
evidence of no difference between the two techniques suggesting TTC was associated with shorter 1 
AoX times and CPB times. However, upon subgroup analysis, we found that TTC was associated with 2 
shorter AoX times and CPB times compared to EABO (femoral) (p=0.02; p=0.05) but not EABO 3 
(aortic). EABO (aortic) was associated with shorter AoX times and CPB times compared to TTC 4 
(p<0.001; p=0.13). These results show that, out of all three approaches, EABO (aortic) is associated 5 
with the shortest AoX times and CPB times. Reasons for this may include an easier and more 6 
straightforward cannulation manoeuvre compared to femoral cannulation and a more reliable 7 
occlusion of the aorta than with TTC. In addition, surgeon learning curve is an important confounder 8 
to consider for this outcome. It is a difficult confounder to control for because in most cases the 9 
reports from operations performed at the early stages of the surgeon learning curve were not 10 
separated from those when surgeons had gained more experience. An example of bias caused by 11 
confounding due to changes over time is found in Mazine et al. (2013).18 In this study, the 12 
experience from 2006 to 2009, when EABO was available, was compared with the experience from 13 
2009 to 2011, when TTC was available. With the same surgeons operating, the potential for 14 
confounding due to surgeon learning curve suggests that these surgeons were less experienced both 15 
at MIMVS and EABO between 2006 and 2009 compared to when they started using TTC. We know 16 
that EABO is, by the nature of the technique, associated with a longer surgeon learning curve.3 17 
Surgeon experience not only has an impact on intra-operative times but also on clinical outcomes for 18 
patients. In Alturi et al. (2014)20 for example, the authors noticed the learning curve associated with 19 
EABO had a significant impact on the number of iatrogenic aortic dissections in their patients. They 20 
reported a 3% rate of aortic dissection with EABO in their first 100 cases as opposed to only a 0.6% 21 
rate in their last 500. These two examples show how surgeon experience plays an important role in 22 
influencing these outcomes of interest. 23 
 24 
Ten studies reported aortic dissection. Meta-analysis showed lower rates of aortic dissection with 25 
TTC compared to EABO: 4/1590 for the TTC group versus 19/2492 for the EABO group (RR, 0.33, 95% 26 
 
 16 
CI, [0.12] to [0.93], p=0.04). This finding has been previously reported4 and it is thought EABO is 1 
associated with higher rates of aortic dissection because of the need to insert a guidewire in the 2 
femoral artery which can damage the lining of the vessel as well as the need for higher perfusion 3 
pressures with this technique.18 We were unable to perform a subgroup analysis for this outcome 4 
because all studies using EABO (aortic) found no incidence  of aortic dissection to compare to TTC. 5 
 6 
• Quality of evidence and limitations of review 7 
The overall quality of the evidence was low. For AoX times and CPB times, we found substantial 8 
heterogeneity within the results (I2 > 80%). We suspect the heterogeneity to be secondary to 9 
variations in surgeon experience, variations in recording technique of extracorporeal support times 10 
across studies, variations in the types of clamps used in TTC (Chitwood Clamp vs. Cygnet flexible 11 
clamp) as well as the balloons used in EABO (Heartport Endoaortic Clamp (Heartport) vs. EndoClamp 12 
Aortic Catheter (Edwards Lifesciences)) across the studies. Such high levels of heterogeneity (I2 > 13 
80%) suggest it is very difficult to infer anything from these findings because the variation in 14 
measurement technique is too influential. Based on the meta-analysis, the studies included did not 15 
report data on myocardial protection, acute right and/or left ventricular failure and need for post-16 
operative ECMO to achieve a meaningful conclusion in this regard. The literature search, data 17 
collection and analysis have been performed in a transparent and reproducible form. This will have 18 
reduced any risk of bias in the review process.  19 
 20 
Author’s conclusions: 21 
This systematic review and meta-analysis reports safe and similar rates of CVA and survival with 22 
both TTC and EABO in MIMVS. EABO was associated with a higher risk of aortic dissection. EABO 23 




• Implications for research 1 
To this day, all evidence for use of the two occlusion techniques are drawn from observational 2 
cohort studies.  At present there is little evidence to support the adoption of one technique over 3 
another other than personal choice. In such a position of true equipoise we would therefore 4 
encourage the careful design of a randomised control trial comparing TTC and EABO, in specific 5 
participant subgroups. Adoption of a RCT design would remove the heavy bias of confounding 6 
factors. In our opinion, a threshold of 100 operations could be used to determine adequate surgeon 7 
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Tables and figures: 1 
 
Figure 1: Study flow diagram according to the PRISMA (Preferred Reporting 
Items for Systematic reviews and Meta-Analysed) statement. 
 
 
Figure 2: Funnel plot analysis of all-cause mortality for TTC vs EABO. On the 




Figure 3: Forest plot of primary outcomes with pooled risk ratios (diamonds) and 
95% confidence intervals (CIs) (horizontal lines). Sizes of the squares are 
proportional to the weight of each study. 
 
Figure 4: Forest plot for AoX-clamp and CPB times (min) with mean differences 
(diamonds) and 95% confidence intervals (CIs) (horizontal lines). Sizes of the 






Table 1: Included studies with patient characteristics.
Study Country Study type 
Type of Transthoracic 
Clamp (TTC) 
Type of Endoaortic Balloon 
































Aybek (2000)11 Germany Prospective 
Chitwood Clamp (Scanlan 
International, Inc, St Paul, 
MN) 
Heartport Endoaortic Clamp (Heartport, 
Redwood City, CA) - Femoral cannulation 





45.7 52.2 2.9 0 
Reichenspurner (2005)12 Germany Retrospective 
Chitwood Clamp (Scanlan 
International, Inc, St Paul, 
MN) 
EndoClamp (Cardiovation, Ethicon Inc 
Somerville, NJ) – Femoral cannulation 
120 60 60 62.1  10.5 70.8 NA NA 
Maselli (2006)15 Italy Prospective 
Chitwood Clamp (Scanlan 
International, Inc, St Paul, 
MN) 
Cardiovations EndoClamp Aortic 
Catheter (Edwards LifeSciences 
Corporation, Irvine, CA) – Aortic 
cannulation 





70 75 NA NA 
Ius (2009)16 Italy Retrospective 
Cygnet Flexible Clamp 
(Novare Surgical Systems 
Inc., Cupertino, CA) 
EndoClamp Aortic Catheter (Edwards 
LifesSiences Corporation, Irvine, CA) – 
Femoral cannulation 
127 95 32 62  11 63  9 50.5 40.6 NA NA 
Modi (2009)19 USA Prospective NA NA – Femoral cannulation 1052 573 479 61.1  13.9 51% Not recorded 
Glower (2010)21 USA Retrospective 
Cosgrove Flexible Clamp 
(Cardinal Health V, Edwards 
LifeSciences Corporation, 
Irvine, CA) 
EndoClamp Aortic Catheter (Edwards 
Lifesciences Corporation, Irvine, CA) – 
Aortic cannulation 
671 235 436 58  14 59  13 59.1 52.5 NA NA 
Loforte (2010)17 Italy Retrospective 
Cygnet Flexible Clamp 
(Novare Surgical Systems 
Inc., Cupertino, CA) 
EndoClamp Aortic Catheter (Edwards 
Lifesciences Corporation, Irvine, CA) – 
Femoral cannulation 





73.1 77.7 NA NA 
Mazine (2013)18 Canada Retrospective 
Chitwood Clamp (Scanlan 
International, Inc, St Paul, 
MN) 
Cardiovations EndoClamp Aortic 
Catheter (Edwards LifeSciences 
Corporation, Irvine, CA) – Femoral 
cannulation 
243 103 140 61.9  11 
55.4  
1.9 
38.8 40 5.8 6.4 
Alturi (2014)20 USA Retrospective 
Chitwood Clamp (Scanlan 
International, Inc, St Paul, 
MN) 
EndoClamp Aortic Catheter (Edwards 
Lifesciences Corporation, Irvine, CA) – 
Femoral cannulation 





52.4 42.5 NA NA 
Bentala (2015)13 Netherlands Retrospective 
Chitwood Clamp (Scanlan 
International, Inc, St Paul, 
MN) 
EndoClamp Aortic Catheter, IntraClude 
Intra-Aortic Occlusion Device (Edwards 
LifeScience Corporation, Irvine, CA) – 
Femoral cannulation 
221 57 164 62 66 43.9 43.9 7 1.9 
Barbero (2016)14 Italy Retrospective 
Chitwood Clamp (Scanlan 
International, Inc, St Paul, 
MN) 
Endoreturn/ IntraClude Intra-Aortic 
Occlusion Device (Edwards LifeScience 
Corporation, Irvine, CA) – one group (1) 
with femoral cannulation, the other (2) 





















7 Chitwood Clamp 
2 Cygnet Flexible Clamp 
1 Cosgrove Flexible Clamp 
1 not specified 
1 Heartport Endoaortic Clamp 
7 EndoClamp 
2 IntraClude Intra-Aortic Occlusion 
Device 
1 not specified 





Table 2: Assessment of risk of bias using ROBINS-I. 
Study name 
 
1. Bias due to 
confounding 
2. Bias in selection 
of participants 
3. Bias in 
classification of 
interventions 
4. Bias due to departures 
from intended 
intervention 
5. Bias due to 
missing data 
6. Bias in 
measurement 
outcomes 
7. Bias in selection 
of the reported 
result 
Overall 
risk of bias 
Aybek (2000)11 Serious Low Low Low Low Low Moderate Serious 
Reichenspurner 
(2005)12 
Serious Low Low Low Low Low Moderate Serious 
Maselli (2006)15 Moderate Low Low Low Low Low Moderate Moderate 
Ius (2009)16 Serious Low Low Low Moderate Low Moderate Serious 
Modi (2009)19 Serious Low Low Low Low Low Moderate Serious 
Glower (2010)21 Serious Low Low Low Low Low Moderate Serious 
Loforte (2010)17 Serious Low Low Low Low Low Moderate Serious 
Mazine (2013)18 Serious Low Low Low Low Low Moderate Serious 
Alturi (2014)20 Serious Low Low Low Low Low Moderate Serious 
Bentala (2015)13 Moderate Low Low Low Low Low Moderate Moderate 




Summary of findings:  
TTC compared to EABO for minimally invasive mitral valve surgery (MIMVS) 
Patient or population: patients undergoing minimally invasive mitral valve surgery (MIMVS) 
Setting: cardiac surgery 
Intervention: TTC  
Comparison: EABO  
Outcomes Anticipated absolute effects* (95% CI)  Relative effect 
(95% CI)  
№ of participants  
(studies)  




Risk with EABO 
(with technical 
subgroups) 
Risk with TTC 
Cerebrovascular 
Accident (CVA)  
19 per 1,000  
16 per 1,000 
(9 to 27)  
RR 0.83 
(0.48 to 1.44)  
4145 
(11 observational studies)  
⨁◯◯◯ 
VERY LOW  
 
I2 = 6% 
All-cause mortality  
11 per 1,000  
17 per 1,000 
(9 to 29)  
RR 1.52 
(0.86 to 2.66)  
4181 
(12 observational studies)  
⨁◯◯◯ 
VERY LOW  
 
I2 = 0% 
Aortic dissection  
7 per 1,000  
2 per 1,000 
(1 to 7)  
RR 0.33 
(0.12 to 0.93)  
4145 
(11 observational studies)  
⨁◯◯◯ 
VERY LOW  
 
I2 = 0% 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% 
CI).  
 
CI: Confidence interval; MD: Mean difference; RR: Risk ratio  
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different 
Low certainty: The true effect may be substantially different from the estimate of the effect 
Very low certainty: The true effect is likely to be substantially different from the estimate of effect  
 










Summary of findings:  
TTC compared to EABO (with technical subgroups) for minimally invasive mitral valve surgery (MIMVS) 
Patient or population: patients undergoing minimally invasive mitral valve surgery (MIMVS)  
Setting: cardiac surgery 
Intervention: TTC  
Comparison: EABO (with technical subgroups)  
Outcomes Anticipated absolute effects* (95% CI)  Relative 
effect 
(95% CI)  
№ of participants  
(studies)  




Risk with EABO (with technical 
subgroups) 
Risk with TTC 
Cross Clamp Time 
(min) - TTC vs. 
Femoral cannulation 
EABO  
The mean cross Clamp Time (min) 
- TTC vs. Femoral cannulation 
EABO was 0 minutes  
The mean cross Clamp Time (min) - TTC 
vs. Femoral cannulation EABO in the 
intervention group was 9.26 minutes 
faster (17 to 1.52 minutes faster)  








I2 = 84% 
  
Cross Clamp Time 
(min) - TTC vs. Aortic 
cannulation EABO  
The mean cross Clamp Time (min) 
- TTC vs. Aortic cannulation EABO 
was 0 minutes  
The mean cross Clamp Time (min) - TTC 
vs. Aortic cannulation EABO in the 
intervention group was 7.77 minutes 
faster (3.29 to 12.26 minutes longer)  








I2 = 0% 
Cardiopulmonary 
Bypass (CPB) time 
(min) - TTC vs. 
Femoral cannulation 
EABO  
The mean cardiopulmonary Bypass 
(CPB) time (min) - TTC vs. Femoral 
cannulation EABO was 0 minutes  
The mean cardiopulmonary Bypass 
(CPB) time (min) - TTC vs. Femoral 
cannulation EABO in the intervention 
group was 10.08 minutes faster (19.93 to 
0.22 minutes faster)  









I2 = 87%  
Cardiopulmonary 
Bypass (CPB) time 
(min) - TTC vs. Aortic 
cannulation EABO  
The mean cardiopulmonary Bypass 
(CPB) time (min) - TTC vs. Aortic 
cannulation EABO was 0 minutes  
The mean cardiopulmonary Bypass 
(CPB) time (min) - TTC vs. Aortic 
cannulation EABO in the intervention 
group was 10.89 minutes longer (3.37 
minutes faster to 25.15 minutes longer)  









I2 = 79% 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% 
CI).  
 
CI: Confidence interval; MD: Mean difference; RR: Risk ratio  
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different 
Low certainty: The true effect may be substantially different from the estimate of the effect 
Very low certainty: The true effect is likely to be substantially different from the estimate of effect  
 
Table 4: Summary of findings table for secondary outcomes. 
